AIM
BHVN icon

Aigen Investment Management’s Biohaven BHVN Stock Holding History

Aigen Investment Management’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-6,594
Closed -$229K – 742
2024
Q2 		$229K Buy
+6,594
New +$261K 0.04% 589

Other funds holding BHVN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Aigen Investment Management's BHVN Position: Q3 2024 in Review

Aigen Investment Management sold out of Biohaven (BHVN) in Q3 2024, closing a stake of 6,594 shares — an estimated $229K sold.

Aigen Investment Management first reported a position in BHVN in Q2 2024 and held it in 1 quarter. The position peaked at $229K in Q2 2024. 254 funds tracked by Wall St. Rank hold BHVN as of Q3 2024.

  • Aigen Investment Management reported no remaining Biohaven position as of Q3 2024 after selling out during the quarter.
  • Aigen Investment Management sold 6,594 Biohaven shares in Q3 2024, an estimated $229K.
  • Aigen Investment Management first reported a position in Biohaven in Q2 2024 and held it in 1 quarter.
  • Aigen Investment Management's Biohaven position peaked at $229K in Q2 2024.
  • 254 funds tracked by Wall St. Rank held Biohaven as of Q3 2024.

Based on Aigen Investment Management's 13F filing for Q3 2024, filed 5 Nov 2024.